Tachosil Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

The growth in the historic period can be attributed to increasing surgical procedure volumes, growing adoption of collagen-based hemostatic products, expansion of transplant and cardiovascular surgeries, availability of advanced surgical materials, improved clinical outcomes with fibrin-based patches.

The growth in the forecast period can be attributed to increasing demand for bioactive surgical materials, rising investments in advanced wound care solutions, expansion of minimally invasive surgery adoption, growing focus on surgical efficiency, increasing innovation in biodegradable hemostatic technologies. Major trends in the forecast period include increasing use of advanced surgical hemostats, rising adoption of patch-based hemostatic solutions, expansion of minimally invasive surgical procedures, growing demand for rapid bleeding control products, enhanced focus on post-surgical healing outcomes.

The rapid increase in surgical procedures is expected to drive the growth of the TachoSil market in the coming years. Surgical procedures are medical interventions performed by trained surgeons to diagnose, treat, or repair injuries, diseases, or abnormalities in the body. The growth in surgical procedures is fueled by the rising prevalence of chronic diseases, advancements in medical technologies, and increasing demand for minimally invasive treatments. TachoSil is used during surgeries to ensure effective hemostasis and tissue sealing, reducing complications and improving surgical outcomes. For instance, in June 2025, Intuitive Surgical, Inc., a US-based publicly traded medical device company, reported that its surgical system was used in 2,286,000 procedures in 2023, rising to 2,683,000 procedures in 2024. Therefore, the surge in surgical procedures is driving the growth of the TachoSil market.

The increase in accidents is also contributing significantly to the expansion of the TachoSil market. Accidents are unplanned events causing injury, damage, or harm, often arising from human error, environmental conditions, or mechanical failures. Factors such as increased vehicle usage, distracted driving, and insufficient road safety measures have led to a rise in accidents. TachoSil serves as a hemostatic patch in accident-related injuries, controlling bleeding and supporting tissue sealing during surgical or traumatic interventions. For instance, in July 2025, Transport Canada reported that in 2023, road accident fatalities reached 3,030, injuries totaled 233,853 (a 4.1% increase), across 173,364 road accidents (also a 4.1% increase). Thus, the rise in accidents is fueling the growth of the TachoSil market.

In July 2024, Corza Medical, a US-based manufacturer of innovative surgical technologies, acquired Takeda’s TachoSil manufacturing operations for an undisclosed amount. Through this acquisition, Corza Medical aims to enhance operational capabilities, streamline supply chains, and improve customer service worldwide. This move is expected to boost manufacturing capacity and support the introduction of new products within its biosurgery portfolio. Takeda Pharmaceutical Company, based in Japan, was the original manufacturer of TachoSil.

Major companies operating in the tachosil market are Corza Medical.

North America was the largest region in the tachosil market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tachosil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tachosil market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Tariffs are influencing the tachosil market by raising costs of imported collagen matrices, fibrinogen components, sterile packaging materials, and specialized manufacturing equipment. Surgical centers in North America and Europe are most affected due to reliance on imported biologic raw materials, while Asia-Pacific faces higher costs in product distribution. These tariffs are increasing production expenses and procurement costs for hospitals. At the same time, they are encouraging regional sourcing of biomaterials, localized manufacturing investments, and innovation in cost-efficient surgical sealant technologies.

The tachosil market research report is one of a series of new reports that provides tachosil market statistics, including tachosil industry global market size, regional shares, competitors with a tachosil market share, detailed tachosil market segments, market trends and opportunities, and any further data you may need to thrive in the tachosil industry. This tachosil market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Tachosil is a surgical hemostatic patch designed to control bleeding and promote tissue sealing during surgical procedures. Composed of a collagen matrix and fibrinogen, it adheres to tissue, supports clot formation, and enhances hemostasis. Its primary purpose is to reduce blood loss and aid tissue healing across various surgical settings.

The main indications for Tachosil include cardiovascular surgery, orthopedic surgery, general surgery, transplant surgery, and neurosurgery. Cardiovascular surgery involves the repair, replacement, or reconstruction of heart and blood vessel structures to treat conditions such as heart disease, valve disorders, and arterial blockages. Tachosil is available in liquid and patch formulations and is distributed through hospitals, specialty clinics, and ambulatory surgical centers.

The tachosil market consists of sales of surgical adhesion barriers, wound care products, and hemostatic agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.